3 days ago · Vantive builds on a 70-year legacy of kidney care leadership and innovation, with a singular focus on empowering patients and care teams with more flexible, collaborative and accessible care options ... Vantive, formerly the Baxter Kidney Care segment, today launched as a new standalone vital organ therapy company following the completion of ...

Vantive will build on Baxter’s nearly 70-year commitment to pioneering therapies for kidney patients and providers across modalities. Products will include peritoneal dialysis devices and solutions; connected technologies like the Sharesource remote patient management system; organ support therapies including continuous renal replacement ...

2 days ago · DEERFIELD, Ill., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Vantive, formerly the Baxter Kidney Care segment, today launched as a new standalone vital organ therapy company following the completion of its ...

Aug 13, 2024 · Baxter International Inc. (NYSE:BAX), a global medtech leader, and funds managed by global investment firm Carlyle (NASDAQ:CG) today announced that they have signed a definitive agreement under which Carlyle is to acquire Baxter's Kidney Care segment, to be named Vantive, for $3.8 billion.

Jul 25, 2023 · Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that Vantive will be the name of the company’s proposed spinoff of its Renal Care and Acute Therapies businesses. Vantive is expected to launch as an independent, publicly traded company by July 2024 or earlier, subject to satisfaction of customary conditions.

Introducing Vantive, a newly independent healthcare company focused on vital organ therapies. Over the last seven decades, we have built a legacy of exceptional kidney care products and services. Now we are deepening our commitment to elevating the patient and clinician dialysis experience through digital solutions and advanced services while ...

Aug 13, 2024 · NEW YORK (Reuters) -Buyout firm Carlyle Group struck a deal to acquire Baxter’s kidney-care unit Vantive for $3.8 billion, the companies said on Tuesday. The proceeds from the deal, which is...

2 days ago · DEERFIELD, Ill., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Vantive, formerly the Baxter Kidney Care segment, today launched as a new standalone vital organ therapy company following the completion of its ...

Aug 13, 2024 · Provides increased flexibility to deploy capital toward opportunities to accelerate Baxter’s and Vantive’s respective growth objectives; Represents key milestone in Baxter’s ongoing business transformation, enabling heightened strategic clarity, …

Aug 13, 2024 · Under the terms of the definitive agreement, subject to certain closing adjustments, Baxter will receive approximately $3.5 billion in cash with net after-tax proceeds currently estimated...